Christopher Austin is global head of Orrick’s Capital Markets practice and co-lead of Orrick’s global Fintech team, helping many industry participants navigate this complex and evolving sector. He focuses on capital markets and corporate law, with extensive experience in public offerings, public company representations and securities law compliance.
Chris counsels technology companies of all sizes and stages of development, including advising on formation, venture financings, mergers and acquisitions, initial public offerings, corporate governance, and intellectual property issues. He is a recognized leader in capital markets work for investment banks, including BAML, Goldman Sachs, J.P. Morgan and Morgan Stanley, in connection with initial public offerings and follow-on offerings of technology and life sciences companies.
His recent transactions include the initial public offerings of Arcadia BioScience, Benefitfocus, Eloqua, On Deck, Ooma, Paylocity and Rapid7, multiple public offerings of Intercept Pharmaceuticals stock, and venture capital financings and secondary stock transactions for Betterment and SoFi.